2025-12-31-accounts

THE INSULIN DEPENDENT DIABETES TRUST

Registered Number: 3148360 Charity Number: 1058284

---

THE INSULIN DEPENDENT DIABETES TRUST

_____________

TRUSTEES’ REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

THE INSULIN DEPENDENT DIABETES TRUST

CONTENTS

	Page
Charity Information	1
Trustees’ Report	2 - 9
Independent Examiner’s Report	10
Statement of financial activities	11
Balance sheet	12
Notes to the financial statements	13 - 25

THE INSULIN DEPENDENT DIABETES TRUST

CHARITY INFORMATION

Trustees

Trustees
	Mrs J M D Hirst MBE, Co-Chair
	Dr M Kiln, Co-Chair
	Mr Abban Qayyum
	Ms C Baker
	Mr J Birbeck
	Mrs G Coleman
	Mr Ken Heard
	Mrs L Ingram
Company registered
number	3148360
Charity registered
number	1058284
Registered office	210 Abington Avenue
	Northampton
	Northamptonshire
	NN1 4PR
Bankers	Virgin Money
	7 Gold Street
	Northampton
	NN1 1EN
Investment advisors	MPA
	98 High Street
	Henley in Arden
	B95 5BY
Accountants	Paul Slater & Co
	1A Washington Street
	Northampton
	NN2 6NN

1

THE INSULIN DEPENDENT DIABETES TRUST

TRUSTEES’ REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

Company and banking details etc

The Trustees present their annual report together with the financial statements of the Insulin Dependent Diabetes Trust (IDDT) for the year 1 January 2025 to 31 December 2025. The Annual Report serves the purpose of both a Trustees’ report and a directors’ report under company law. The Trustees confirm that the Annual Report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company’s governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard in the UK and Republic of Ireland.

Since the Company qualifies as small under section 382 of the Companies Act 2006, the Strategic report of medium and large companies under the Companies Act 2006 (Strategic Report and Directors’ regulations 2013) have been omitted.

Objectives and activities

a. Policies and objectives

In setting and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance ‘Public benefit, running a charity (PB2)’.

b. Strategies for achieving objectives

The purposes of the charity as set out in its governing document remain unchanged:

• To continue our activities to help children and their parents.

• To reach more people with Type 1 or Type 2 diabetes through publicity.

• To try to ensure that pork insulin continues to remain available for those who require it.

• To fund research aimed at improving the lives of people with diabetes now.

• To supply information booklets to health professionals at no charge to encourage them to give the booklets to their patients so they receive information and become aware of the help IDDT can offer.

c. Activities undertaken to achieve the objectives

Despite the uncertain economic climate during the year faced by the country and people generally, the Trustees recognised that the purposes of the charity should remain the same, but some of our activities to achieve the aims and objectives had to be reduced or suspended. Nevertheless, to the best of our ability, the following activities were carried out:

• To reach more people with Type 1 or Type 2 diabetes to offer information and support.

• To continue our activities to help children with diabetes and their parents with the provision of information to them and to teachers to enable them to better understand the needs of children with diabetes in schools.

• To ensure widespread distribution of existing booklets to provide insight, information and support with the aim of improving quality of life and reducing hospital admissions. This includes the supply of free information booklets to healthcare professionals to encourage them to give the booklets to their patients so they receive information and become aware of the help IDDT can offer.

• Continuing the promotion of the help the Charity can offer through letters to the editors of local newspapers.

• To increase advertising of key booklets in healthcare professional journals.

• To continue to review the GDPR regulations and to ensure that IDDT is compliant.

2

THE INSULIN DEPENDENT DIABETES TRUST

• During 2025, IDDT continued to collect unwanted, in-date insulin and other diabetes items to send to help people with diabetes in Ukraine. Knitted goods were also donated to help children in Ukraine and these were sent to orphanages, three collections of items were sent to Ukraine during 2025.

• IDDT continued the planned Facebook advertising campaign during 2025. This was organised by Orange Juice in consultation with the staff of IDDT. IDDT’s membership increased with each Facebook advert.

• In 2023, IDDT joined the Goodwill Partnership to offer ‘Make Your Will for Free’ to IDDT members, not the general public. This has attracted members to make Wills and so this was continued during 2024 and 2025.

• To continue to develop and update information booklets. In addition, with the success of previous ‘Diabetes Diaries’, a Diabetes Diary for 2026 was published and again this proved popular with our members.

• The number of people in the lottery has varied slightly but this has produced an income for the Charity of around £10,000 during 2025.

• The IDDT booklets have continued to be extremely popular with people with diabetes and healthcare professionals and they are regularly reviewed and updated. As in previous years, the booklets relating to diet ‘Diabetes – Everyday Eating’ and ‘Diet and Diabetes’ have continued to be the most popular. We have sent out in the region of 170,000 booklets during 2025, the majority being sent to healthcare professionals..

• The number of health professionals becoming members continues to increase showing that advertising in diabetes-related journals is successful so it has continued during 2025. It means that increasing numbers of people with diabetes learn about IDDT from their healthcare professionals.

• The online shop has continued to be popular, especially for Christmas cards.

• IDDT funded research continued to be suspended during 2025 due to the Charity’s financial position and the need to carry out policies that enable the Trust to continue to reach people with diabetes.

d. Social Investment policies

The Charity continued to operate the policies and procedures document relating to fundraising and sponsorship for the Trust approved in 2015. The interest generated continues to assist in supporting the Charity’s causes.

e. Grant-making policies

The Trust has made the decision to continue to suspend research funding to safeguard the financial future of the Charity due to the country’s financial uncertainties.

f. Main activities undertaken to further the Charity’s purposes for the public benefit

The Charity works hard to promote various ways people can live with diabetes and lead fulfilled and happy lives. The booklets and newsletters all extend help and support. Our helpline offers one to one assistance, the demand for which increases as a result of the reduced numbers of General Practice face to face appointments and hospital clinic appointments being delayed or cancelled.

Achievements and performance

a. Main achievements of the Charity

The main achievements during 2025 have been as follows:

Financial

• The income from legacies was approximately the same as in 2024 but the number of pending legacies was lower than in previous years.

• There has been an increase in the numbers of members paying by standing order and the number of members making larger donations continued to increase during 2025.

• The Lottery income remained static during 2025.

3

THE INSULIN DEPENDENT DIABETES TRUST

Membership

• Membership has increased during 2025 by approximately 1,000 from 2024, with the Facebook advertising playing a significant role in this.

• Membership of healthcare professionals has also increased and they continued to contact IDDT for copies of booklets during 2025 and in increasing numbers.

• It was clear that during 2024 and 2025 many people are not receiving medical/nursing help or advice they need to manage their diabetes, so the Charity has received many more requests for help, information or just an opportunity to talk from both members and nonmembers.

Footcare

• The number of requests from people with diabetes for help in relation to footcare was significant during 2025 as many people have still been unable to have their regular foot checks. Our booklet ‘Looking After Your Feet’ proved particularly useful by people with diabetes and podiatrists.

• The sale of neuropads to help people care for their own feet remained steady during the year.

Booklets, Newsletters and Type 2 & You

• A major part of our work is to support people living with diabetes and we have continued to receive requests for the above during 2025.

• The Newsletter and Type 2 & You have been sent out quarterly and continue to be well received.

• As a result of the good response to the Diabetes Diary 2025, a similar Diary was published for 2026.

• Shopping List continued to be sold during 2025, and especially before Christmas, to aid people with meal planning.

• In 2025 we again produced a Christmas brochure of items for sale which included Christmas cards and the sales were higher than the previous year and we believe this was due to the increase in members from the Advertising Campaign of 2024.

IDDT Annual Event

In October 2025, IDDT held its AGM and Event which was well attended by members and their families. The group discussions were popular and the speakers were well received and the feedback from delegates was that the day was very informative and enjoyable.

It was announced that Anne Aubin and Veronica Readman who resigned as Trustees during 2024 were made Honorary Trustees as a mark of gratitude for all their work and support they have given to IDDT over their years of involvement.

Durning 2025, the two new trustees who had been co-opted to the Board, Mabel Blades and Karen Merrey, attended the Trustee meetings and were formally elected at the AGM. The Charity is grateful to them.

Key performance indicators

The Key performance indicators include:

• Investments

• Legacy income

• Income from members

• Membership numbers

• Numbers of members with Type 1 diabetes, Type 2 diabetes, parents, carers and healthcare professionals

• Advertising and response rates

• Social media activity.

4

THE INSULIN DEPENDENT DIABETES TRUST

c. Review of activities

During 2025, IDDT rebooked the same conferences as before the pandemic, including the Diabetes Professional Conference (DPC). This is the largest health professional conference, but as a result of changes in organisation, IDDT was not a sponsor in 2025. As expected, the attendance was high as it was free for healthcare professionals to attend and the subsequent requests for our booklets was also high. However, we continued with our advertising in professional journals which also resulted in increased requests for booklets which were much appreciated.

IDDT continues to keep an international presence. Providing information and support to people with diabetes wherever they live forms an important part of the Charity’s activities. In addition, the Charity continues to provide information and support to people in need of porcine insulin.

IDDT is the UK arm of Insulin for Life but since 2022, IDDT has been collecting unwanted insulin and other diabetes items to help people with diabetes in Ukraine. IDDT started collecting supplies in 2022 worth over £400,000 and similar amounts were supplied during 2023, 2024 and 2025. The Trustees would like to thank the individuals and healthcare professionals who have made these donations and also the staff for their work in dealing with the unwanted items and packing for delivery into Ukraine. This work continues in 2025.

d. Factors relevant to achieve objectives

The short and longer term aims and objectives

• The Charity continues to publish a free quarterly Newsletter and a slightly shorter version called ‘Type 2 & You’ for people with Type 2 diabetes not taking insulin. People with Type 2 diabetes taking insulin and tablets receive both newsletters. We encourage people to access these online, but the majority of people prefer hard copy versions.

• The aim of the Charity still is to support research in line with its’ aims by funding research that investigates ways of making life easier for those who already have diabetes. However, the Trustees carried forward to 2025 their decision to put all research funding on hold to safeguard the financial future of the Charity during the present financial uncertainties.

• To maintain the Charity’s independence by encouraging voluntary donations and legacy income.

e. Fundraising activities and income generation

The Charity relies on grant aid from donors identified in the accounts and the Trustees are most appreciative of this support. There are minor fundraising activities which include Christmas card sales, books, and aids to help with caring for the feet.

f. Investment policy and performance

The Trustees have resolved to establish reserves for future activities and they have wide powers of investment. The policy on reserves is that establishing assets are retained to produce income, income which is wholly used to support existing activities. There is no intention in the long-term to either increase or reduce the capital held. The policy is justified in that it is necessary to preserve income at present levels in order to maintain the activities of the Charity.

During 2025, the investments remained the same to limit income fluctuations due to the economic climate, and this justifies the policy of safeguarding the Charity’s future, especially as there never are any guarantees associated with legacy income.

Financial review

a. Going concern

The operations and business activities of the Charity have been impacted by the economic climate. However, after making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

5

THE INSULIN DEPENDENT DIABETES TRUST

b. Reserves policy

IDDT complies with Charity Commission Guidelines

IDDT has a Research and Welfare Fund

• All monies donated for research are allocated to fund research at the time of the donation/legacy, but during 2025 no legacies were donated to the research fund.

• Monies not designated for research are allocated to the General Fund for welfare purposes.

• These allocations are made at the time of receipt.

Short-term and long-term investments

We have 5 to 10 year investments. All investments have the facility for easy access to funds. These are monitored through our investment portfolio and with regular meetings with our Financial Advisers.

Cash reserves

All legacy income is paid into IDDT’s Legacy account and transfers are made as/when necessary to the current account for running expenses.

Day to day income

Cash, cheques and credit cards are paid into the current account with Virgin Money. Standing order payments are paid into a Barclays Bank current account and transferred into the Virgin Money current account on a regular basis. During 2025, Barclays Bank requested details of all the Trustees which we felt were intrusive, so we made a complaint which was ultimately satisfactorily dealt with.

Lottery income

The Lottery income is paid into a stand-alone account and the profits paid into the Virgin Money Bank current account on a regular basis.

c. Principle risks and uncertainties

The Trustees cannot find any major risks to which the Charity is exposed each financial year when preparing and updating the strategic plan, in particular those relating to operations and finances of the Charity.

A risk register has been established. Procedures are in place to ensure compliance with health and safety of staff and visitors to the offices. Internal control risks are minimised by the implementation of procedures for the authorisation for all transactions and projects.

d. Principal funding

The principal sources of income are from legacies and voluntary donations. The Trustees are aware of the need to generate regular income and are continuing to take steps to achieve this. The Trustees are very grateful for the continued generosity of the members in making donations and especially to the increasing numbers of people who make regular donations through their bank. They also wish to record their gratitude to the donors of legacies and donations in memory of loved ones for their kindness in helping other people with diabetes.

The Trustees would also like to express their thanks for the continuing support and help of members and their families which provides encouragement to the staff and Trustees to continue with the aims and objectives of IDDT. This support reflects the needs of people living with diabetes to be represented by a patient/carer-based Charity that understands their needs and remains independent and uninfluenced by outside financial influences.

Considering the small numbers of members of staff and the amount of work covered, the Trustees would like to thank the staff for their continued dedication and hard work during 2025.

The Trustees reaffirm their commitment and determination to try to ensure that people with diabetes and their families have informed choices of treatment, and the access to them that they deserve and need. There have been some improvements in the care but there is lack of services, annual checks

6

THE INSULIN DEPENDENT DIABETES TRUST

and face to face consultations in many areas which is of great concern. The Trustees fear that the consequences of this will be an increase in diabetic complications in people with diabetes and are committed to try to raise awareness of this and to encourage people with diabetes to insist on receiving the care they need.

Structure, governance and management

a. Constitution

The Insulin Dependent Diabetes Trust is registered as a charitable company limited by guarantee and was set up by a Memorandum of Association.

b. Methods of appointment or election of Trustees

The directors of the company are also charitable Trustees for the purposes of Charity law and under the company’s Articles of Association are known as the Board of Trustees. Under the requirements of the Memorandum and Articles of Association the members of the Board of Trustees are elected to serve for a period of three years, after which they must be re-elected at the next Annual Meeting.

Due to the nature of the work of the Charity and the importance of understanding the needs of and representation of people with diabetes and their families, at no time shall the number of Trustees who are medically qualified or are allied health professionals exceed twenty five per cent of the total number of Trustees. The Charity records the particular skills of the Trustees in order to maintain a broad mix of skills and expertise.

c. Organisational structure and decision-making policies

A Board of a maximum of 11 Trustees administer the Charity, covering policy, membership and finances. Minor day to day decisions are taken by the Co-Chairs and Operations Manager. Modern technology enables consultations to be made easily and quickly. Major decisions on future policies are taken at the AGM for the approval of members.

During 2025, the staff team has remained the same with a slight change of hours, so there are three members of staff on 30 hour weeks and one on a 24 hour week. The Charity will continue to update staff skills when required to ensure their skills and knowledge remain relevant and up to date. The Charity contracts out the website work, PR and press releases, social media, IT support and day to day finances.

The Charity continued to operate the policies and procedures document relating to fundraising and sponsorship for the Trust approved in 2015. The day to day running of the Charity is carried out by Co-Chairs and Operations Manager.

d. Policies adopted for the induction and training of the Trustees

The Trustees are familiar with the practical work of the Charity. New Trustees are encouraged to take short training sessions to familiarise themselves with:

• The responsibilities of Trustees.

• The documents and the Memorandum and Articles of Association for the operations of the Charity.

• The current financial position and sources of funding of the Charity.

• The objectives and forward plans for the Charity.

e. Pay policy for key management personnel

IDDT has one key management person

• Operations Manager

There is a line management structure in place.

7

THE INSULIN DEPENDENT DIABETES TRUST

Pay Review

The Trustees review staff salaries for the following year at their November meeting. The general principle is to give pay increases in line with inflation.

f. Related party relationships

The Charity maintains its links with people and groups in other countries around the world. The Charity continues to offer support and information to people in other countries, especially those in need of animal insulin. Providing information and support wherever people live continue to be a major role.

The Trustees wish to thank Wockhardt UK for their ongoing supply of porcine insulin. At the end of 2025, Wockhardt announced that they would no longer produce porcine insulin in vials but would continue to supply it in cartridges. They also announced the availability of a new pen, the mypen2, to replace the discontinued Autopen for the porcine cartridges. IDDT is aware of the vulnerable position people who need porcine insulin are in because of adverse effects when using synthetic GM insulins.

Plans for future periods

The Charity’s strategies for achieving its’ aims and objectives in the future

• The Charity continues to publish new booklets to inform and support people with diabetes and to prevent the development of complications. The need for this appears to have increased as a result of people having less access to their usual healthcare team and face to face appointments.

• The Charity’s aim to prevent amputations continues to be a major activity by using the booklet ‘Looking After Your Feet’ which highlights how people can care for their feet at home and when they should seek professional help. This is combined with selling neuropad online and through our Christmas brochure and by advertising in journals for podiatrists.

• During 2025 the Charity continued to try to encourage people to take exercise and to adopt healthy eating. This will continue during 2026.

• The website continues to be a valuable way of reaching people living with diabetes and the Charity employs a webmaster to regularly update and monitor traffic. The plan is that during 2026, the website will be redesigned. New members, orders for booklets and other items are received through the website.

• The Newsletter and Type 2 & You are available in large print for people who are visually impaired.

• The Charity continued to attend healthcare professional conferences in order to demonstrate to healthcare professionals the availability of IDDT booklets they can offer to their patients.

• To continue to keep informed about the latest research and changes in government and NHS policies in order to keep our members and website visitors informed.

Statement of Trustees’ responsibilities

The Trustees (who are also directors of the Company for the purposes of company law) are responsible for preparing the Trustees’ report and financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year. Under Company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and its incoming resources and application of resources, including income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

• select suitable accounting policies and then apply them consistently;

• observe methods and principles of the Charities SOR (FRS 102);

8

THE INSULIN DEPENDENT DIABETES TRUST

• make judgments and accounting estimates that are reasonable and prudent;

• state whether applicable UK Accounting Standards (FRS 2) have been followed, subject to any material departures disclosed and explained in the financial statements;

• prepare the financial statements on the ongoing concern basis unless it is inappropriate to presume that the Company will continue in business.

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Company’s transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence taking reasonable steps for the prevention and detection of fraud and other irregularities.

Disclosure of information to Accountants

Each of the persons who are Trustees at the same time when this Trustees’ report is approved has confirmed that:

• so far as that Trustee is aware, there is no relevant information of which the Charity’s accountants Paul Slater & Co are unaware, and

• that Trustee has taken all steps that ought to have been undertaken as a Trustee in order to be aware of any relevant information and to establish that the Charity’s accountants are aware of that information.

Approved by order of the members of the Board of Trustees and signed on their behalf by:

Mrs J M D Hirst MBE

Date:

9

THE INSULIN DEPENDENT DIABETES TRUST

REPORT OF THE INDEPENDENT EXAMINER TO THE TRUSTEES OF THE CHARITABLE COMPANY ON THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2025

I report to the Trustees on my examination of the accounts of the above Charity for the year ended 31 December 2025.

Respective responsibilities of Trustees and Independent Examiner

As the Charity’s Trustees, you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011.

The Trustees consider that the audit requirement of Section 144(1) of the Charities Act 2011 (the Act) does not apply, and that there is no requirement in the memorandum and articles of the Charity for the conducting of an audit, and that the accounts do not require an audit in accordance with Part 16 of the Companies Act 2006 and that no member or members have requested an audit pursuant to section 476 of the Companies Act 2006. As a consequence, the Trustees have elected that the financial statements be subject to independent examination.

I report in respect of my examination on the Trust’s accounts carried out under Section 145 of the 2011 Act and in carrying out my examination, I have followed all the applicable Directions given by the Charity Commission under Section 145 950 9B0 of the Act.

Basis of Examiner’ Statement and scope of work undertaken

The Charity’s gross income exceeded £250,000 and I am qualified to undertake the examination by being a qualified member of AAT.

No matters have come to my attention in connection with the examination which gives me cause to believe that the accounting records were kept in accordance with Section 130 of the Charities Act or the accounts did not accord with the accounting records or the accounts did not comply with the applicable requirements concerning the form and contents of accounts set out in the Charities Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.

Mrs T Loughran – Independent Examiner FMAAT, MIP

1A Washington Street Kingsthorpe Northampton NN2 6NN

This report was signed on

10

THE INSULIN DEPENDENT DIABETES TRUST

STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2025

		Restricted	Unrestricted	Total	Total
		funds	funds	funds	funds
		2025	2025	2025	2024
	Note	£	£	£	£
Income from:
Donations & Legacies	3	0	415,399	415,399	252,125
Ukraine donations	3	0	150	150	53
Fundraising	4	0	1,713	1,713	8,194
Income from Investments	5	0	18,882	18,882	37,110
Other income	6	0	31,433	31,433	33,939
Gift aid	7	0	8,066	8,066	7,323
		__	__	__	__
Total income		0	475,643	475,643	338,744
		__	__	__	__
Expenditure on:
Raising funds		0	17,783	17,783	20,689
Charitable activities and
governance costs	8	0	671,341	671,341	654,616
		__	__	__	__
Total expenditure		0	689,124	689,124	675,305
		__	__	__	__
Net gains (losses) on
Investments		0	44,471	44,471	65,291
		__	__	__	__
Net movement in funds		0	(169,010)	(169,010)	(271,270)
		__	__	__	__
Reconciliation of funds:
Total funds brought forward		0	2,552,879	2,552,879	2,824,149
Net movement in funds		0	(169,010)	(169,010)	(271,270)
		__	__	__	__
Total funds carried forward		0	2,383,869	2,383,869	2,552,879
		__	__	__	__

11

THE INSULIN DEPENDENT DIABETES TRUST

	BALANCE SHEET AS AT 31	BALANCE SHEET AS AT 31	DECEMBER 2025
			2025		2024
	Note		£		£
Fixed assets
Tangible assets	13		358,340		359,965
Investments	14		1,973,387		2,105,042
			__		__
Total fixed assets			2,331,727		2,465,007
Current assets
Stocks	15	13,479		14,370
Debtors		7,452		6,542
Cash at bank and in hand		42,467		80,491
		__		__
Total current assets		63,398		101,403
Creditors: amounts falling
due within one year	16	(11,256)		(13,531)
		__		__
Net current assets			52,142		87,872
			__		__
Total assets less current liabilities			2,383,869		2,552,879
			__		__
Total net assets			2,383,869		2,552,879
			__		__
Charity funds
Unrestricted funds	17		2,383,869		2,552,879
			__		__
Total charity funds			2,383,869		2,552,879
			__		__

For the financial year in question the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

No members have required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:

Mrs J M D Hirst MBE

12

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

1. General information

The Charity is a company limited by guarantee, registered in England and Wales. The registered office is as noted in the Trustee’s Report.

2. Accounting policies

2.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and the Republic of Ireland (FRS 102) (Issued in October 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

The Insulin Dependent Diabetes Trust meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

2.2 Going concern

The operations and business activities of the Charity has been impacted by the recent COVID-19 outbreak. However, after making appropriate enquiries, the Trustees have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

2.3 Income

All income is recognised once the Company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

The recognition of income from legacies is dependent on establishing entitlement, the probability of receipt and the ability to estimate with sufficient accuracy the amount receivable. Evidence of entitlement to a legacy exists when the Company has sufficient evidence that a gift has been left to them (through knowledge of the existence of a valid Will and the death of the benefactor) and the executor is satisfied that the property in question will not be required to satisfy claims in the estate. Receipt of a legacy must be recognised when it is probable that it will be received and the fair value of the amount receivable, which will generally be the expected cash amount to be distributed to the Company, can be reliably measured.

Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.

Other income is recognised in the period in which it is receivable and to the extent the goods have been provided or on completion of the service.

13

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

2.4 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party. It is probable that a transfer of economic benefit will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up to the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributed to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources.

Expenditure on raising funds includes all expenditure incurred by the Company to raise funds for its charitable purposes and includes costs of all fundraising activities, events and non-charitable trading.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Company’s objectives, as well as any associated support costs.

All expenditure is inclusive of irrecoverable VAT.

2.5 Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Company; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

2.6 Tangible fixed assets and depreciation

Tangible fixed assets costing £1,000 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives.

Depreciation is provided on the following basis:

Office Equipment - 20% reducing balance Computer equipment - 20% reducing balance

The freehold property is not depreciated as the depreciation would be immaterial.

14

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

2.7 Investments

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance Sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Statement of financial activities.

2.8 Stocks

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Costs includes all direct costs.

2.9 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

2.10 Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Company anticipated it will pay to settle the debt or the amount it has received as advanced payments for the goods and services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation.

2.11 Financial instruments

The Company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

2.12 Pensions

The Company operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Company to the fund in respect of the year.

2.13 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Company and which have not been designated for other purposes.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Company for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the Notes to the financial statements.

15

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

3. Income from donations and legacies

	Unrestricted	Total	Total
	funds	funds	funds
	2025	2025	2024
	£	£	£
Legacies
S Johnson	128,959	128,959	0
D Dalzell	1,000	1,000	0
C King	1,000	1,000	0
I Scott-Tillbrook	6,000	6,000	0
A Gripton	12,000	12,000	0
J Green	11,445	11,445	0
H Bouch-Jones	174,275	174,275	0
C Smith	21,267	21,267	80,000
J Bushnell	0	0	10,000
G Duff	0	0	5,000
J Dunhill	0	0	68,287
C Giles	0	0	2,000
M Griffiths	0	0	5,000
M Haufbauer	0	0	1,000
P Hobson	4,350	4,350	25,000
P Dervish	0	0	2,873
	__	__	__
Subtotal detailed disclosure	360,296	360,296	199,160
	__	__	__
Donations	53,607	53,607	52,068
Legacies under £1,000	1,496	1,496	950
	__	__	__
Subtotal	55,103	55,103	53,018
	__	__	__
Total	415,399	415,399	252,178
	__	__	__

16

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

4. Income from other trading activities

Income from fundraising events

		Unrestricted	Total	Total
		funds	funds	funds
		2025	2025	2024
		£	£	£
	Fundraising	1,713	1,713	8,194
		__	__	__
5.	Income from investments
		Unrestricted	Total	Total
		funds	funds	funds
		2025	2025	2024
		£	£	£
	Investment income	18,882	18,882	37,110
		__	__	__
6.	Other income resources
		Unrestricted	Total	Total
		funds	funds	funds
		2025	2025	2024
		£	£	£
	Sales of goods and lottery	29,593	29,593	28,536
	Conferences/AGM	1,513	1,513	1,349
	Dream Trust	327	327	0
		__	__	__
		31,433	31,433	33,939
		__	__	__

17

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

7. Gift Aid

	Unrestricted	Total	Total
	funds	funds	funds
	2025	2025	2024
	£	£	£
Gift Aid	8,066	8,066	7,323
	__	__	__

8. Analysis of expenditure on charitable activities

Summary by fund type

	Restricted	Unrestricted	Total	Total
	funds	funds	funds	funds
	2025	2025	2025	2024
	£	£	£	£
Charitable activities	0	671,341	671,341	654,616
	__	__	__	__
	__	__	__
Total 2024	0	654,616	654,616
	__	__	__
Analysis of expenditure by activities
	Activities
	Undertaken	Support	Total	Total
	Directly	costs	funds	funds
	2025	2025	2025	2024
	£	£	£	£
Charitable activities	589,819	81,522	671,341	654,616
	__	__	__	__
	__	__	__
Total 2024	575,642	78,974	654,616
	__	__	__

9. Analysis of expenditure by activities

18

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

Analysis of direct costs
	Charitable	Total	Total
	Activities	funds	funds
	2025	2025	2024
	£	£	£
Staff Costs	123,302	123,302	127,363
Private healthcare	2,845	2,845	3,679
Project Vera	0	0	4,609
Merchandise for promotion	1,086	1,086	0
Temporary staff	0	0	180
Travel, subsistence and meetings	1,022	1,022	1,624
Marketing and advertising	96,828	96,828	65,699
Research and editorial costs	56,184	56,184	53,004
Health and Safety	776	776	347
Professional indemnity costs	1,855	1,855	1,743
Website and IT	38,993	38,993	23,837
Printing costs	94,337	94,337	85,198
Direct Mail	107,574	107,574	89,261
Conference, information and meeting costs	29,513	29,513	70,901
Charitable activities - Pensions	3,132	3,132	4,148
Bookkeeping fees	2,105	2,105	3,595
Equipment hire	8,850	8,850	11,257
Charges for investments	18,778	18,778	28,376
Ukraine expenditure	150	150	821
Other legal and professional	2,489	2,489	0
	__	__	__
	589,819	589,819	575,642
	__	__	__
Analysis of support costs
	Charitable	Total	Total
	Activities	funds	funds
	2025	2025	2024
	£	£	£
Governance salary costs	26,340	26,340	23,214
Depreciation	1,625	1,625	2,031
Legal and professional	7,560	7,560	8,625
Telephone and internet	324	324	338
Printing, postage and stationery	37,111	37,111	34,705
HR Training and welfare – staff	1,031	1,031	1,026
Rates and water charges	222	222	2,205
Bank Charges	739	739	795
Cleaning and waste management	1,153	1,153	1,109
Premises costs, repairs and renewals	5,417	5,417	4,926
	__	__	__
	81,522	81,522	78,974
	__	__	__

19

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

10. Auditors’ remuneration

		2025	2024
		£	£
	Fees payable to the Company’s auditors for the audit of
	the Company’s annual accounts	0	0
		__	__
11.	Staff costs
		2025	2024
		£	£
	Wages and salaries	119,441	117,748
	Social security costs	3,861	9,615
		__	__
		123,302	127,363
		____	____

The average number of persons employed by the Company during the year was as follows:

	2025	2024
	No.	No.
Employees	4	5
	__	__
The number of employees whose employee benefits exceeded £60,000 was:
	2025	2024
	No.	No.
In the band £60,001 to £70,000	0	0
	__	__

12. Trustees’ remuneration and expenses

With the agreement of the Charities Commission Mrs J M D Hirst’s remuneration is for extensive research, publications and editorial work. Mrs Hirst attends meetings, conferences and seminars on behalf of the Charity to lecture on the rights to retain a choice of insulins. Her continued contribution to the work of the Charity is invaluable. The value of the Trustees’ remuneration and other benefits is fees of £56,184 (2024 £53,004).

During the year ended 31 December 2025, no Trustee expenses have been incurred ( 2024 - £NIL )

20

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

13. Tangible fixed assets

		Freehold	Office
		Property	Equipment	Total
		£	£	£
	Cost or valuation
	At 1 January 2023	351,842	60,676	412,518
	Additions	0	0	0
		__	__	__
	At 31 December 2025	351,842	60,676	412,518
		__	__	__
	Depreciation
	At 1 January 2025	0	52,553	52,553
	Charge for the year	0	1,625	1,625
		__	__	__
	At 31 December 2024	0	54,178	54,178
		__	__	__
	Net book value
	At 31 December 2025	351,842	6,498	358,340
		__	__	__
	At 31 December 2024	351,842	8,123	359,965
		__	__	__
14.	Fixed asset investments
				Unlisted
				Investments
				£
	Cost or valuation
	Transfers between classes			1,973,387
				__
	At 31 December 2025			1,973,387
				__
	Net book value
	At 31 December 2025			1,973,387
				__
	Investment portfolios have previously been treated as current asset		investments.

21

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

15. Stocks

	2025	2024
	£	£
Finished goods and goods for resale	13,479	14,370
	__	__
Creditors: Amounts falling due within one year
	2025	2024
	£	£
Trade creditors	8,808	8,716
Other creditors – Pension and PAYE	2,448	4,815
	__	__
	11,256	13,531
	__	__

16. Creditors: Amounts falling due within one year

22

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

17. Statement of funds

Statement of funds – current year

					Balance at
	Balance at				31
	1 January			Gains/	December
	2025	Income	Expenditure	(Losses)	2025
	£	£	£	£	£
Unrestricted funds
Reserves	2,552,879	475,643	(689,124)	44,471	2,383,869
	__	__	__	__	__
Total of funds	2,552,879	475,643	(689,124)	44,471	2,383,869
	__	__	__	__	__
Statement of funds – prior year
					Balance at
	Balance at				31
	1 January			Gains/	December
	2024	Income	Expenditure	(Losses)	2024
	£	£	£	£	£
Unrestricted funds
Reserves	2,824,149	338,744	(675,305)	65,291	2,552,879
	____	____	____	____	____
Total of funds	2,824,149	338,744	(675,305)	65,291	2,552,879
	__	__	__	__	__

23

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

18. Analysis of net assets between funds

Analysis of net assets between funds – current year

	Restricted	Unrestricted	Total
	funds	funds	funds
	2025	2025	2025
	£	£	£
Tangible fixed assets	0	358,340	358,340
Fixed asset investments	0	1,973,387	1,973,387
Current assets	0	63,398	63,398
Creditors due within one year	0	(11,256)	(11,256)
	__	__	__
Total	0	2,383,869	2,383,869
	__	__	__
Analysis of net assets between funds – prior year
	Restricted	Unrestricted	Total
	funds	funds	funds
	2024	2024	2024
	£	£	£
Tangible fixed assets	0	359,965	359,965
Fixed asset investments	0	2,105,042	2,105,042
Current assets	0	101,403	101,403
Creditors due within one year	0	(13,531)	(13,531)
	__	__	__
Total		2,552,879	2,552,879
	__	__	__
19. Reconciliation of net movement in funds to net cash flow from		operating activities
		2025	2024
		£	£
Net income for the year (as per Statement of Financial	Activities)	(169,010)	(271,270)
		__	__
Adjustments for:
Depreciation charges		1,625	2,031
Gains/(losses) on investments		44,471	65,291
Decrease/(increase) in stocks		1,191	(4,879)
Increase/(decrease) in creditors		(2,275)	191
		__	__
Net cash provided by operating activities		45,012	62,634
		__	__

24

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

20. Analysis of cash and cash equivalents

			2025	2024
			£	£
Cash in bank			42,467	80,491
			__	__
Total bank and bank equivalents			42,467	80,491
			__	__
Analysis of changes in net debt
	At 1		Other non-	At 31
	January	Cash	cash	December
	2025	flows	changes	2025
	£	£	£	£
Cash at bank	80,491	(38,024)	0	42,467
Liquid investments	139,188	0	0	139,188
	__	__	__	__
	219,679	(38,024)	0	181,655
	__	__	__	__

21. Analysis of changes in net debt

22. Pension commitments

The Charity operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the Charity in an independently administered fund. The pension cost charge represents contributions payable by the Charity to the fund and amounted to £3,132 (2024 - £4,148).

23. Post Balance Sheet events

The Charity is confident that it has the sufficient reserves and resources to continue operating and therefore the Trustees consider it to be a going concern.

25